RPS6KB1 and glioblastoma: Next, we surveyed the expression of YB-1, CCT4, mLST8, and phospho-S6K1 (T389) using a cohort of glioblastoma patient samples (Supplemental Table 1) by performing IHC assays (Figure 8B).